In this randomized clinical trial (RCT) comparing two forms of clinical decision support (CDS) prevention, interruptive CDS ...

In a cohort of adults with chronic obstructive pulmonary disease (COPD), receiving fluticasone-umeclidinium-vilanterol was ...

Tumor Treating Fields therapy demonstrates increased overall survival in patients with unresectable pancreatic cancer. The ...

In this prospective cohort, there was a significantly increased risk of developing cardiovascular disease (CVD) in the ...

Imfinzi reduced risk of death by 27% and reduced disease progression by 24% compared to patients receiving a placebo. 2. In ...

Investigating the effects of home-based rehabilitation after intensive inpatient rehabilitation on motor function, activities ...

High volume-rate echocardiography for simultaneous imaging of electromechanical activation and cardiac strain of the whole heart in a single heartbeat in humans 1. Non-invasive high volume-rate ...

In this randomized controlled trial, it was found that GA2, a late-arresting, genetically attenuated Plasmodium falciparum ...

1. In this cluster-randomized controlled trial, it was found that a pneumococcal conjugate vaccine (PCV) schedule involving a single primary dose plus a booster (1p+1) was noninferior to previously ...

1. Median progression-free survival was 9.4 months in the imlunestrant–abemaciclib group vs 5.5 months in the imlunestrant group with HR 0.57 (significant) and 5.6 months in the imlunestrant group vs ...